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Abstract In the present study, we demonstrate an animal
model and recently introduced size–based exclusion method
for circulating tumor cells (CTCs) isolation. The methodology
enables subsequent in vitro CTC-culture and characterization.
Human lung cancer cell line H460, expressing red fluorescent
protein (H460-RFP), was orthotopically implanted in nude
mice. CTCs were isolated by a size-based filtration method
and successfully cultured in vitro on the separating membrane
(MetaCell®), analyzed by means of time-lapse imaging. The
cultured CTCs were heterogeneous in size and morphology
even though they originated from a single tumor. The outer
CTC-membranes were blebbing in general. Abnormal mitosis
resulting in three daughter cells was frequently observed. The
expression of RFP ensured that the CTCs originated from lung
tumor. These readily isolatable, identifiable and cultivable
CTCs can be used to characterize individual patient cancers
and for screening of more effective treatment.
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Introduction
The detection of circulating tumour cells (CTCs) in the pe-
ripheral blood of patients with solid epithelial tumors holds a
great promise, and many exciting separation technologies
have been developed over the past years [1].
However, detecting CTCs remain technically challenging.
CTCs are present at very low concentrations of one tumor cell
in the background of millions of blood cells. Extremely sen-
sitive methods are required for their identification and char-
acterization. Nevertheless, presence of CTCs could be an
evidence for disease progress towards cancer dissemination
[2, 3]. However, the role of CTCs as a disease marker may be
unique under different clinical conditions and should be care-
fully interpreted. Clinical validation of these new biomarkers
requires analysis of CTCs throughout the course of in vivo
and in vitro studies.
Animal model studies using orthotopic metastatic models
could help to identify the role of CTCs as potential biomarker,
enabling mutational analysis and functional testing of metas-
tasis expansion from CTCs.
In the present study, we demonstrate a method for CTC
isolation based on size exclusion from an orthotopic nude
mouse model of human lung cancer labeled with RFP (red
fluorescent protein), using capillary-action-driven blood flow
though porous membranes. The separating membranes can be
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used for in vitro culture of the CTCs immediately after CTCs-
enrichment process.
Materials and Methods
Cell Culture The human H460 lung cancer cell line, express-
ing RFP, used in this study has been described previously [4].
The cells were grown in RPMI-1640 medium supplemented
with 10 % fetal bovine serum (FBS) and gentamicin (Life
Technologies, Carlsbad, CA) to 70–80 % confluence as de-
scribed previously [5].
Orthotopic Model of H460-RFP in Nude Mice A
subcutaneously-growing H460-RFP tumor fragment
(1 mm3) from a single nude mouse was implanted by surgical
orthotopic implantation (SOI) into the left lobe of the left lung
in additional nude mice (group of eight animals). The animals
were kept under isoflurane anesthesia during surgery. All
procedures of the operation were performed with a 6.3×
magnification microscope (Olympus, Tokyo, Japan), (Fig. 1).
Orthotopically-growing H460-RFP demonstrates aggres-
sive metastatic behaviour [4]. Animal experiments were carried
out in accordance with the Guidelines for the Care and Use of
Laboratory Animals under NIH Assurance No. A3873-1.
Isolation and Culture of the Circulating Tumor Cells from
Blood Blood (0.5–1.0 ml) was obtained from the nude mouse
by cardiac puncture 1 month after orthotopic implantation of
H460-RFP. The blood was placed in an EDTA tube (BD). A
size-based separation method for viable CTC- enrichment
(MetaCell®, Ostrava, Czech Republic) by filtration of the
peripheral blood (PB) through a porous polycarbonate mem-
brane (8 μm diameter pores) was used.
The membrane filters along with the plastic ring were
transferred to 6-well tissue culture dishes (Fig. 1). RPMI
1640 medium (4 ml) with 10 % FBS is added on top of the
filter, and CTCs were then cultured on the membrane at 37 °C,
5 % CO2. After 14 days, the CTCs were cultured directly on
the plastic dish surface or microscopic slides (Lab-Tek Cham-
bered Coverglass, Thermo Fisher Scientific, Rochester, U.S.)
for further confocal microscopy analysis.
Fluorescence Imaging The Olympus OV100 Small Animal
Imaging System (Olympus Corp., Tokyo, Japan) was used for
bright-field and fluorescence imaging of the mice with
orthotopically-implantedH460-GFP. TheOV100 has a sensitive
CCD camera and four objective lenses, parcentered and parfo-
cal, enabling imaging from macrocellular to subcellular [6].
Confocal Imaging A Leica (Wetzler, Germany) TCS SP5
AOBS confocal microscope was used along with a DFC350
FX Digital Camera for 72 h time-lapse imaging.
Results
CTC Isolation In the present report, we used a capillary–
action-driven size-based separation of the CTCs from the
peripheral blood of orthotopic models of human tumors using
the MetaCell® device. A schematic work- flow is shown on
the Fig. 1. The CTCs were detected and separated in PB of all
animals.
Due to the gentle blood flow within the separation
process, caused by natural forces of capillary action, the
enriched CTCs remained viable on the separating poly-
carbonate membrane (Fig. 2). The viability is evidenced
by the expression of RFP-protein in the captured cells
(Fig. 2b, c, d).
The CTCs enriched on the membrane, which is hold in
a plastic ring, were then placed directly into a 6-well
culture dish along with cell culture medium (Fig. 1).
The cells were scanned every 12 h and the first mitoses
have been observed after 24 h (Fig. 2c, d). Using this
method, we obtained confluent H460-RFP CTCs culture
within several days. The subsequent growth of confluent
CTC-culture is shown on Fig. 3. Figure 3 is derived from
time–lapse imaging.
CTC-Cytomorphology and Characteristics Generally, the
cultured CTCs exhibited blebbing surfaces (Fig. 4a), the cell
membrane vesicles (blebs) are exhibited already within 3 days
of culture. Another typical characteristics of in vitro growing
CTCs is multinuclear stages with prominent nucleoli
(Fig. 4b).
The CTCs appeared very heterogeneous even if originating
from one primary tumor. They differed in size (11–30μm) and
proliferation capacity as evidenced by the time-lapse imaging
(Fig. 5). Based on the time lapse imaging of the cells in vitro
we may hypothesize that the cells use the blebs on the cell
surface for faster movement if compared to the cells without
blebbing. Morphologically, there is a difference between the
CTC-culture and the original H460–RFP cell culture in the
amount of produced blebs on the cell surface. The CTCs
produce usually more blebs.
Following, irregular CTC-divisions were seen very often;
when one CTC-cell divided into the 3 daughter cells (Fig. 6).
The cell originating from these unbalanced divisions may
harbor a potential to divide again into three daughter cells
within the next mitotic cycle. As shown on the Fig. 6, some of
the 3 daughter cells may enter apoptotic process immediately
after division.
The uncontrolled growth of the CTCs population, with
many irregular mitoses, is in fact generating a population of
the cancer cells significantly different to the primary cell
culture. The CTCs in vitro cultures are definitely worth to
be studied subsequently by immunophenotypization, gene
expression profiling and mutational analysis.
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Fig. 1 Experimental design
Fig. 2 CTCs enriched from the
peripheral blood (PB). PB was
withdrawn from a mouse bearing
H460-RFP human lung cancer
growing orthotopically, 1 month
after implantation. CTCs were
detected on the microporous
polycarbonate filter membrane by
RFP-fluorescence. a, b 6 h after
blood withdrawal. c, d 24 h after
blood withdrawal. The first
mitoses are observed already after
24 h. The CTCs were kept in
RPMI medium with FBS. Scale
bar 10 μm (Leica confocal
microscope TCS SP5 AOBS)
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Discussion
Our aim was to develop a successful CTC isolation method and
CTCs in vitro culture protocol enabling cytomorphological
analysis of viable CTCs. Cytomorphological characterization
of CTCs can be followed by further downstream analysis (e.g.,
karyotype analysis, gene expression analysis of chemoresistance
genes, in vitro chemoresistance monitoring). All the information
on CTCs characteristics can be used for personalizing cancer
treatment [7].
Previously, we have shown the feasibility of culturing
CTCs directly from whole blood using orthotopic
models of human tumors expressing GFP (green fluo-
rescent protein) using immunomagnetic separation of the
CTC cells [5].
In the present study, CTCs were isolated from the H460-
RFP orthotopic metastatic nude-mouse model of lung cancer
by a size-based separation method. The majority of CTC
isolation methods uses epithelial cell-adhesion molecule
(EpCAM) to capture CTCs and cytokeratin (CK) antibodies
to identify CTCs [8]. The weakness of these approaches could
be that the rare cells isolated via EpCAM and/or cytokeratin
(CK) binding may be circulating epithelial cells and more
aggressive cell subpopulations might not have been isolated
at all because they are EpCAMand CK negative [9, 10]. There
is a broad morphological and immunophenotypical variation
within CTCs derived from the same tumor type as we have
realized during our observation.
The EpCAM-dependance could be one of the reasons why
significant differences in separation efficiency have been re-
ported if the immunomagnetic isolation of lung cancer CTCs
(CellSearch®) was compared to size-based filtration CTC-
capture (ISET®) [11].
Therefore, accurate detection of CTCs based on morpho-
logical features such as size could be crucial. Since only a
limited number of CTCs are captured by all, it is important to
expand the isolated CTCs in vitro in order to perform subse-
quent functional analyses.
CTCs have been found to create doublets and clusters in
the blood [12, 13]. Circulating tumor microemboli have been
observed in the peripheral blood of metastatic lung cancer, as
well [11, 14]. The presence of clusters of CTC might be a
relevant prognostic factor for malignancy [15]. However,
large- and variable-sized clusters may not be isolated by
immunomagnetic methods, since clusters may lack sufficient
expression of EpCAM and/or CK. CTCs within clusters may
also be surrounded by blood cells and thus, cannot be detected
or recognized by immunogenic techniques [14, 16]. An ad-
vantage of size-based separation methods could be enabling
the cluster isolation as well.
Fig. 3 CTCs isolated from a tumor bearing mouse (orthotopically-transplanted human H460-RFP), cultured in vitro. The subsequent growth of
confluent CTC-culture is shown derived from time -lapse imaging within 72 h. Scale bar 20 μm
Fig. 4 CTC -proliferation evidenced in vitro, in the culture of CTCs,
isolated from an H460 experimental human lung cancer mice model. a
Cell membrane vesicles starting to be producedwithin 3 days of culture. b
Multi-nuclear stage can be also found very often in the CTCs. The CTCs
were kept in RPMI medium with FBS. Scale bar 10 μm (Leica confocal
microscope TCS SP5 AOBS)
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But there are also differences in the capture efficiency
for the recently introduced size- based separation methods
(e.g. ISET®, ScreeCell®, CellSieve®, MetaCell®). So far
no comparison study has been conducted in the field of size-
based separation methods. The most important difference
between the reported size-based separation methods is that
not all of them enable to capture viable CTCs.
On the other hand methodologies reporting viable CTC-
cells enrichment have also not shown until today, how many
out of the captured CTCs do survive the isolation process and
are able to proceed towards mitotic process. The analytical
reports evidencing the CTC- viability are generally based on
the isolation of the cancer cells out of cell cultures diluted in
the blood samples. One could expect, that these cells will
behave differently, than CTCs isolated from patients’ blood
or animal model.
We believe that data presented in this article, based on the
use of orhotopic metastatic models, could be an unique in vivo
proof of the viable CTCs separation principle.
One could hypothesize, that the use of orthotopical
metastasis models could enhance the validation process
for the size–based separation methods, in general. Having
more viable CTCs leads us faster towards personalized
cancer treatment.
We hope that combination of SOI technique with a use
of cancer cell lines expressing fluorescent protein and
subsequent detection of CTCs/clusters by size-based sepa-
ration method (MetaCell®) could provide easier way for
new anticancer agents testing. The count of CTCs appears
to monitor the response to the treatment, in as little as a
few weeks [13, 16]. Beyond an in vitro number count, an
ex vivo functional study on patient-derived CTCs might
provide a support for an immediate treatment decision
regarding drug resistance [11].
In vitro culturing of CTCs is a base for the proliferation
tests comparing the chemosensitivity. This study demonstrate
a successful culturing of CTCs isolated from animal using
filtration device (MetaCell®), which is as gentle as enabling
obtaining CTCs with very high viability. These protocols can
focus on using the CTCs culture for personalizing the onco-
logical treatment in future.
Fig. 5 CTC proliferation monitored in vitro, in the culture of CTCs
isolated from an H460 experimental human lung cancer mice model-
confocal time-lapse imaging. In vitro culture was started from a single
CTC-cell. One mitotic cycle took approximately 12 h in average. Scale
bar (Leica confocal microscope TCS SP5 AOBS)
Fig. 6 CTCs isolated from a tumor bearing mouse (orthotopically-
transplanted human H460-RFP), cultured in vitro, imaged by time lapse
imaging for 72 h. An irregular mitosis of one dividing cell (in the
multinuclear stage) is shown on the picture. Subsequently three daughter
cells developed. Each daughter-cell divided within the next mitotic cycle
into 3 cells. Afterwards an apoptosis process started (see arrows). The
CTCs were kept in RPMI medium with FBS. Scale bar 10 μm (Leica
confocal microscope TCS SP5 AOBS)
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Conclusion
In vitro culturing of CTCs is a base for the proliferation test
reporting the chemosensitivity. This study demonstrate a suc-
cessful culturing of animal CTCs by use of filtration device
(MetaCell®), which is as gentle as enabling obtaining CTCs
with very high viability. These protocols can focus on using
the CTCs culture for personalizing the oncological treatment
in future.
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